Edith M. Janssen

Immunomodulatory effects of antigen-pulsed macrophages in a murine model of allergic asthma.

CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes.

Upregulation of costimulatory molecules induced by lipopolysaccharide and double-stranded RNA occurs by Trif-dependent and Trif-independent pathways.

CD4+ T-cell help controls CD8+ T-cell memory via TRAIL-mediated activation-induced cell death.

Protein kinase C-theta is an early survival factor required for differentiation of effector CD8+ T cells.

Anti-T-cell Ig and mucin domain-containing protein 1 antibody decreases TH2 airway inflammation in a mouse model of asthma.

The Unc93b1 mutation 3d disrupts exogenous antigen presentation and signaling via Toll-like receptors 3, 7 and 9.

IL-2 gets with the program.

Dendritic cell programming by cytomegalovirus stunts naive T cell responses via the PD-L1/PD-1 pathway.

LXR signaling couples sterol metabolism to proliferation in the acquired immune response.

CD4 cell-secreted, posttranslationally modified cytokine GIF suppresses Th2 responses by inhibiting the initiation of IL-4 production.

Distinct roles of cytolytic effector molecules for antigen-restricted killing by CTL in vivo.

Immunosuppression: learning from the masters.

Cutting edge: merocytic dendritic cells break T cell tolerance to beta cell antigens in nonobese diabetic mouse diabetes.

Prolonged antigen storage endows merocytic dendritic cells with enhanced capacity to prime anti-tumor responses in tumor-bearing mice.

Interleukin-2 rescues helpless effector CD8+ T cells by diminishing the susceptibility to TRAIL mediated death.

Breaking T cell tolerance to beta cell antigens by merocytic dendritic cells.

Immune adjuvant efficacy of CpG oligonucleotide in cancer treatment is founded specifically upon TLR9 function in plasmacytoid dendritic cells.

Nab2 regulates secondary CD8+ T-cell responses through control of TRAIL expression.

Cross-presentation of cell-associated antigens by mouse splenic dendritic cell populations.

Melanoma-infiltrating dendritic cells: Limitations and opportunities of mouse models.

Respond to "No antigen-presentation defect in Unc93b1(3d/3d) (3d) mice".

Harnessing dendritic cells for tumor antigen presentation.

DNA methylation dynamics during ex vivo differentiation and maturation of human dendritic cells.

STING-mediated DNA sensing promotes antitumor and autoimmune responses to dying cells.

Quantitating MHC class II trafficking in primary dendritic cells using imaging flow cytometry.

Loss of Phagocytic and Antigen Cross-Presenting Capacity in Aging Dendritic Cells Is Associated with Mitochondrial Dysfunction.

Ablation of CD8α(+) dendritic cell mediated cross-presentation does not impact atherosclerosis in hyperlipidemic mice.